首页 > 最新文献

Contraception, fertilite, sexualite (1992)最新文献

英文 中文
[Spaniomenorrhea: a tentacular symptom]. 西班牙淋病:一种触手症状。
J Belaisch
{"title":"[Spaniomenorrhea: a tentacular symptom].","authors":"J Belaisch","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":79332,"journal":{"name":"Contraception, fertilite, sexualite (1992)","volume":"27 7-8","pages":"500-5"},"PeriodicalIF":0.0,"publicationDate":"1999-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21359551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Iron and zinc supplementation during pregnancy: interactions and requirements]. [怀孕期间补充铁和锌:相互作用和需求]。
D Bouglé, A Proust

The metabolism of iron and zinc during pregnancy is reported; their deficiency impairs foetal growth, and increases the rate of complications at delivery and of preterm births. Providing iron and zinc supplements must take into account their metabolic interactions which are likely to decrease their bioavailability. Supplementations should be prescribed only during at risk pregnancy and their dosage should be adapted to lessen these side effects and improve their efficiency.

怀孕期间铁和锌的代谢有报道;它们的缺乏会损害胎儿的生长,并增加分娩并发症和早产的发生率。提供铁和锌补充剂必须考虑到它们的代谢相互作用,这可能会降低它们的生物利用度。只有在有风险的怀孕期间才应服用补充剂,其剂量应调整以减轻这些副作用并提高其效率。
{"title":"[Iron and zinc supplementation during pregnancy: interactions and requirements].","authors":"D Bouglé,&nbsp;A Proust","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The metabolism of iron and zinc during pregnancy is reported; their deficiency impairs foetal growth, and increases the rate of complications at delivery and of preterm births. Providing iron and zinc supplements must take into account their metabolic interactions which are likely to decrease their bioavailability. Supplementations should be prescribed only during at risk pregnancy and their dosage should be adapted to lessen these side effects and improve their efficiency.</p>","PeriodicalId":79332,"journal":{"name":"Contraception, fertilite, sexualite (1992)","volume":"27 7-8","pages":"537-43"},"PeriodicalIF":0.0,"publicationDate":"1999-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21359558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Biomarkers and uterine cervical cancer. Are they useful for prognosis of cancer and triage of precancerous lesions?]. [生物标志物与子宫颈癌。]它们对癌症的预后和癌前病变的分类有用吗?
J Salvat, M H Schmidt, A Vincent-Genod, L Slamani, A Martino

Biomarkers are "keys" of oncogenesis. Many applications are soon possible as gene therapy and vaccination. Authors have reviewed different aspects of classical prognosis factors and examined new possibilities of prognosis and selection of precancerous lesions as ASCUS by biomarkers. Ag SCCTA4, HPV typing, microangiogenesis, are the main biomarkers in cervical cancers.

生物标志物是肿瘤发生的“关键”。许多应用将很快成为可能,如基因治疗和疫苗接种。作者回顾了经典预后因素的不同方面,并通过生物标志物研究了预后和癌前病变作为ASCUS的选择的新可能性。Ag SCCTA4、HPV分型、微血管生成是宫颈癌的主要生物标志物。
{"title":"[Biomarkers and uterine cervical cancer. Are they useful for prognosis of cancer and triage of precancerous lesions?].","authors":"J Salvat,&nbsp;M H Schmidt,&nbsp;A Vincent-Genod,&nbsp;L Slamani,&nbsp;A Martino","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Biomarkers are \"keys\" of oncogenesis. Many applications are soon possible as gene therapy and vaccination. Authors have reviewed different aspects of classical prognosis factors and examined new possibilities of prognosis and selection of precancerous lesions as ASCUS by biomarkers. Ag SCCTA4, HPV typing, microangiogenesis, are the main biomarkers in cervical cancers.</p>","PeriodicalId":79332,"journal":{"name":"Contraception, fertilite, sexualite (1992)","volume":"27 7-8","pages":"521-31"},"PeriodicalIF":0.0,"publicationDate":"1999-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21359552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Place of intra-urethral prostaglandin E1 for the treatment of erectile dysfunction]. 【尿道内前列腺素E1用于治疗勃起功能障碍的位置】。
E Amar

Transurethral alprostadil (MUSE) is an effective and safe treatment of erectile dysfunction. Never the less, the result after its exit on the US market two years ago were not as good as the investigational studies which claimed around 60% of success rate. In the literature success rate were between 35% and 40% all together. The MUSE had a better acceptance than the intra-cavernous injection despite a lower success rate (40% vs 75%). Since sildenafil came on the market, it seems that the place of MUSE is reduced because comparative studies give better results for sildenafil than MUSE (70% vs 40%) and of course with a better acceptance. Never the less there are absolute and relative counter-indications to the sildenafil which could benefit to the treatment by MUSE. All the comparative studies, IIC, vs MUSE and sildenafil vs MUSE will be studied in this article. In conclusion MUSE should be used as an alternative and should remain an effective tool that must be available to all physicians dealing with erectile dysfunction, perhaps using new formula with a combination of alprostadil with an alpha-blocker.

经尿道前列地尔(MUSE)是一种安全有效的治疗勃起功能障碍的方法。尽管如此,两年前退出美国市场后的结果并不像声称成功率约为60%的调查研究那样好。在文献中,成功率在35%到40%之间。尽管成功率较低(40% vs 75%),但MUSE的接受度优于海绵内注射。自从西地那非上市以来,MUSE的地位似乎降低了,因为比较研究给出了西地那非比MUSE更好的结果(70% vs 40%),当然也有更好的接受度。然而,对西地那非有绝对和相对的反指征,这可能有利于MUSE的治疗。所有的比较研究,IIC与MUSE和西地那非与MUSE将在本文中进行研究。综上所述,缪斯应该作为一种替代药物,并且仍然是一种有效的工具,所有治疗勃起功能障碍的医生都可以使用,也许可以使用前列地尔和α受体阻滞剂联合使用的新配方。
{"title":"[Place of intra-urethral prostaglandin E1 for the treatment of erectile dysfunction].","authors":"E Amar","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Transurethral alprostadil (MUSE) is an effective and safe treatment of erectile dysfunction. Never the less, the result after its exit on the US market two years ago were not as good as the investigational studies which claimed around 60% of success rate. In the literature success rate were between 35% and 40% all together. The MUSE had a better acceptance than the intra-cavernous injection despite a lower success rate (40% vs 75%). Since sildenafil came on the market, it seems that the place of MUSE is reduced because comparative studies give better results for sildenafil than MUSE (70% vs 40%) and of course with a better acceptance. Never the less there are absolute and relative counter-indications to the sildenafil which could benefit to the treatment by MUSE. All the comparative studies, IIC, vs MUSE and sildenafil vs MUSE will be studied in this article. In conclusion MUSE should be used as an alternative and should remain an effective tool that must be available to all physicians dealing with erectile dysfunction, perhaps using new formula with a combination of alprostadil with an alpha-blocker.</p>","PeriodicalId":79332,"journal":{"name":"Contraception, fertilite, sexualite (1992)","volume":"27 7-8","pages":"548-52"},"PeriodicalIF":0.0,"publicationDate":"1999-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21359561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Conization with positive margins]. [带正边缘的锥形]。
J Gondry, C Vergne, S L Mui, J C Boulanger

We received all conizations performed between 1986 and 1997. The incidence of positive margins conization for cervical intraepithelial neoplasia is 7.8% (23.8% in others studies). Persistent or recurrence disease occur only in 35% of cases; so new treatment is not always usefull and cytology and colposcopy are adequate for follow-up.

我们收到了1986年至1997年间进行的所有手术。宫颈上皮内瘤变的边缘锥化阳性发生率为7.8%(其他研究为23.8%)。持续或复发的疾病仅发生在35%的病例中;所以新的治疗方法并不总是有用,细胞学检查和阴道镜检查就足够了。
{"title":"[Conization with positive margins].","authors":"J Gondry,&nbsp;C Vergne,&nbsp;S L Mui,&nbsp;J C Boulanger","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We received all conizations performed between 1986 and 1997. The incidence of positive margins conization for cervical intraepithelial neoplasia is 7.8% (23.8% in others studies). Persistent or recurrence disease occur only in 35% of cases; so new treatment is not always usefull and cytology and colposcopy are adequate for follow-up.</p>","PeriodicalId":79332,"journal":{"name":"Contraception, fertilite, sexualite (1992)","volume":"27 7-8","pages":"532-6"},"PeriodicalIF":0.0,"publicationDate":"1999-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21359555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Transparent nuclei as a marker of congenital heart disease: 1,682 fetuses with transparent nuclei > or = 2.5 mm]. 【透明核作为先天性心脏病的标志:1682例胎儿透明核>或= 2.5 mm】。
M Perdu, J A Hyett, G Sharland, R S Snijders, K H Nicolaides
{"title":"[Transparent nuclei as a marker of congenital heart disease: 1,682 fetuses with transparent nuclei > or = 2.5 mm].","authors":"M Perdu,&nbsp;J A Hyett,&nbsp;G Sharland,&nbsp;R S Snijders,&nbsp;K H Nicolaides","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":79332,"journal":{"name":"Contraception, fertilite, sexualite (1992)","volume":"27 7-8","pages":"I-V"},"PeriodicalIF":0.0,"publicationDate":"1999-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21359565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Genetic predisposition to breast cancer: a review in April 1998]. [乳腺癌的遗传易感性:1998年4月综述]。
D Stoppa-Lyonnet

The recent identification of the BRCA1 and BRCA2 genes allows to understand in an increasing number of cases the origin of a breast/ovarian cancer family history and thereby to propose genetic testing to at risk women. However to know to be carrier of a predisposing germline mutation is at the present to deal with the difficult choice of different supportive cares: close follow up or prophylactic surgery. Numerous studies still have to be done to determine the better management of women at risk. The other challenges are the understanding of the origin of each breast or ovarian cancer case; to identify the factors which modify the tumor risks in predisposed women; and finally to win the social acceptance of genetic testing avoiding any discrimination.

最近对BRCA1和BRCA2基因的鉴定使越来越多的病例能够了解乳腺癌/卵巢癌家族史的起源,从而建议对高危妇女进行基因检测。然而,了解易感生殖系突变的携带者目前面临着不同支持护理的艰难选择:密切随访或预防性手术。为了确定如何更好地管理处于危险中的妇女,还需要进行大量的研究。其他挑战是了解每个乳腺癌或卵巢癌病例的起源;确定易患女性肿瘤风险的改变因素;最后赢得社会对基因检测的接受,避免任何歧视。
{"title":"[Genetic predisposition to breast cancer: a review in April 1998].","authors":"D Stoppa-Lyonnet","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The recent identification of the BRCA1 and BRCA2 genes allows to understand in an increasing number of cases the origin of a breast/ovarian cancer family history and thereby to propose genetic testing to at risk women. However to know to be carrier of a predisposing germline mutation is at the present to deal with the difficult choice of different supportive cares: close follow up or prophylactic surgery. Numerous studies still have to be done to determine the better management of women at risk. The other challenges are the understanding of the origin of each breast or ovarian cancer case; to identify the factors which modify the tumor risks in predisposed women; and finally to win the social acceptance of genetic testing avoiding any discrimination.</p>","PeriodicalId":79332,"journal":{"name":"Contraception, fertilite, sexualite (1992)","volume":"27 7-8","pages":"517-20"},"PeriodicalIF":0.0,"publicationDate":"1999-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21359553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Post-abortion counseling]. 流产后咨询。
I Tamian-Kunegel

Faced with the silence that follows an abortion, we have established an individual, post-abortion counseling program based on psychological interviews with women who have recently had an abortion. These interviews begin in the second week following the abortion when the woman returns to the hospital for a post-abortion medical examination. The point of these interviews is to listen to what has been experienced--notably a certain ambivalence that arises from the act of having the abortion, which is constructed as having been a decision freely taken. The aim of these sessions is to help the woman through the process of mourning. Whether due to the failure of a contraceptive or a failed relationship, the resulting sorrow is produced by an underlying wish to have children. The periodic interviews have, over the weeks, helped to restore a certain psychological balance.

面对堕胎后的沉默,我们建立了一个基于对最近堕胎妇女的心理访谈的个人堕胎后咨询项目。这些面谈在堕胎后第二周开始,当时妇女返回医院进行堕胎后医学检查。这些采访的重点是倾听他们的经历——尤其是堕胎行为所产生的某种矛盾心理,堕胎被认为是一个自由做出的决定。这些会议的目的是帮助妇女通过哀悼的过程。无论是由于避孕失败还是由于一段失败的关系,由此产生的悲伤都是由想要孩子的潜在愿望产生的。几个星期以来,定期的采访有助于恢复某种心理平衡。
{"title":"[Post-abortion counseling].","authors":"I Tamian-Kunegel","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Faced with the silence that follows an abortion, we have established an individual, post-abortion counseling program based on psychological interviews with women who have recently had an abortion. These interviews begin in the second week following the abortion when the woman returns to the hospital for a post-abortion medical examination. The point of these interviews is to listen to what has been experienced--notably a certain ambivalence that arises from the act of having the abortion, which is constructed as having been a decision freely taken. The aim of these sessions is to help the woman through the process of mourning. Whether due to the failure of a contraceptive or a failed relationship, the resulting sorrow is produced by an underlying wish to have children. The periodic interviews have, over the weeks, helped to restore a certain psychological balance.</p>","PeriodicalId":79332,"journal":{"name":"Contraception, fertilite, sexualite (1992)","volume":"27 7-8","pages":"544-7"},"PeriodicalIF":0.0,"publicationDate":"1999-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21359557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Sequential media: why and how?]. [顺序媒体:为什么和如何?]。
Y Ménézo, J Chouteau, C Guyader-Joly, A Veiga

Blastocyst transfer is highly recommended for the following indications to avoid repeated failure of implantation: related to maternal, paternal and cytogenetic aspects on the embryonic side and/or uterus motility. Sequential media have now replaced coculture in order to produce blastocysts. The basic idea of sequential media is to follow embryo's need. There are 2 phases during preimplantation period: the first one corresponds to a development through maternal stores, gathered during maturation, before genomic activation. This requires a complete protection against free radicals (through EDTA), and a decrease in the concentration of glucose and phosphate: mitocondrial function is impaired. Regulation of the endogenous pool is not perfect. Then at the time of genomic activation, there is an increased need for numerous metabolites. Insulin can be added as the I-Receptor appears at the 8-cell stage. The medium used during this phase has to be rich.

强烈建议在以下适应症中进行囊胚移植,以避免植入反复失败:与母体、父亲和胚胎侧的细胞遗传学方面和/或子宫运动有关。为了产生囊胚,顺序培养基现在已经取代了共培养。序贯培养基的基本思想是遵循胚胎的需要。着床前有两个阶段:第一个阶段对应于在成熟期间收集的母体储存的发育,在基因组激活之前。这需要对自由基的完全保护(通过EDTA),以及葡萄糖和磷酸盐浓度的降低:线粒体功能受损。对内生资金池的监管并不完善。然后在基因组激活的时候,对许多代谢物的需求增加。当i受体在8细胞阶段出现时,可以添加胰岛素。在此阶段使用的介质必须是丰富的。
{"title":"[Sequential media: why and how?].","authors":"Y Ménézo,&nbsp;J Chouteau,&nbsp;C Guyader-Joly,&nbsp;A Veiga","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Blastocyst transfer is highly recommended for the following indications to avoid repeated failure of implantation: related to maternal, paternal and cytogenetic aspects on the embryonic side and/or uterus motility. Sequential media have now replaced coculture in order to produce blastocysts. The basic idea of sequential media is to follow embryo's need. There are 2 phases during preimplantation period: the first one corresponds to a development through maternal stores, gathered during maturation, before genomic activation. This requires a complete protection against free radicals (through EDTA), and a decrease in the concentration of glucose and phosphate: mitocondrial function is impaired. Regulation of the endogenous pool is not perfect. Then at the time of genomic activation, there is an increased need for numerous metabolites. Insulin can be added as the I-Receptor appears at the 8-cell stage. The medium used during this phase has to be rich.</p>","PeriodicalId":79332,"journal":{"name":"Contraception, fertilite, sexualite (1992)","volume":"27 6","pages":"449-51"},"PeriodicalIF":0.0,"publicationDate":"1999-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21298057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Results of oocyte donation in France (Study Group on Oocyte Donation)]. 【法国卵母细胞捐赠结果(卵母细胞捐赠研究组)】。
P Fénichel, H Letur-Könirsch, B Martin-Pont, C Mathieu, F Thépot

The French study group on oocyte donation, named GEDO, reports the results concerning the oocyte donation activity in France during 1998, including information from all the centers in effective operation except one. These data describe the recipients' and donors' situation and give the analysis of the results obtained.

法国卵母细胞捐赠研究小组GEDO报告了1998年法国卵母细胞捐赠活动的结果,包括除一个中心外所有有效运作的中心的信息。这些数据描述了受援者和捐助者的情况,并对所获得的结果进行了分析。
{"title":"[Results of oocyte donation in France (Study Group on Oocyte Donation)].","authors":"P Fénichel,&nbsp;H Letur-Könirsch,&nbsp;B Martin-Pont,&nbsp;C Mathieu,&nbsp;F Thépot","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The French study group on oocyte donation, named GEDO, reports the results concerning the oocyte donation activity in France during 1998, including information from all the centers in effective operation except one. These data describe the recipients' and donors' situation and give the analysis of the results obtained.</p>","PeriodicalId":79332,"journal":{"name":"Contraception, fertilite, sexualite (1992)","volume":"27 6","pages":"457-9"},"PeriodicalIF":0.0,"publicationDate":"1999-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21298059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Contraception, fertilite, sexualite (1992)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1